Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report)’s share price fell 6.4% on Friday . The stock traded as low as $2.62 and last traded at $2.62. 3,663 shares changed hands during mid-day trading, an increase of 189% from the average session volume of 1,266 shares. The stock had previously closed at $2.80.
Propanc Biopharma Trading Down 6.4 %
The company’s 50-day moving average price is $5.45 and its 200 day moving average price is $3.35.
About Propanc Biopharma
Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.
Featured Articles
- Five stocks we like better than Propanc Biopharma
- Expert Stock Trading Psychology Tips
- Google Is Betting Big on Nuclear Reactors—Should You?
- What Are Growth Stocks and Investing in Them
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- Upcoming IPO Stock Lockup Period, Explained
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for Propanc Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Propanc Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
